• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reversible Glomerular Thrombotic Microangiopathy Associated With Nintedanib in a Kidney Transplant Recipient.

作者信息

Ouellet Gabriel, Picard Cécile, Rabeyrin Maud, Buron Fanny, Lestelle François, Bellière Julie, Koenig Alice, Thaunat Olivier, Morelon Emmanuel, Charmetant Xavier

机构信息

Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.

CHU de Québec - Université Laval, Quebec City, Quebec, Canada.

出版信息

Kidney Int Rep. 2025 Apr 12;10(6):2069-2070. doi: 10.1016/j.ekir.2025.04.015. eCollection 2025 Jun.

DOI:10.1016/j.ekir.2025.04.015
PMID:40630286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12231014/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b4/12231014/8b7cba9a958c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b4/12231014/8b7cba9a958c/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b4/12231014/8b7cba9a958c/gr1.jpg

相似文献

1
Reversible Glomerular Thrombotic Microangiopathy Associated With Nintedanib in a Kidney Transplant Recipient.肾移植受者中与尼达尼布相关的可逆性肾小球血栓性微血管病
Kidney Int Rep. 2025 Apr 12;10(6):2069-2070. doi: 10.1016/j.ekir.2025.04.015. eCollection 2025 Jun.
2
Nintedanib-induced glomerular microangiopathy: a case report.尼达尼布致肾小球微血管病：病例报告。
CEN Case Rep. 2020 Nov;9(4):295-300. doi: 10.1007/s13730-020-00474-w. Epub 2020 Apr 11.
3
Nintedanib-Induced Renal Thrombotic Microangiopathy.尼达尼布诱发的肾血栓性微血管病。
Case Rep Nephrol Dial. 2021 Jul 22;11(2):227-232. doi: 10.1159/000517692. eCollection 2021 May-Aug.
4
Post-transplant Thrombotic Microangiopathy.移植后血栓性微血管病
J Am Soc Nephrol. 2025 May 1;36(5):940-951. doi: 10.1681/ASN.0000000645. Epub 2025 Jan 31.
5
Pegylated Liposomal Doxorubicin and Kidney-Limited Thrombotic Microangiopathy in a Kidney Transplant Recipient: A Case Report.聚乙二醇化脂质体阿霉素与肾移植受者的肾脏局限性血栓性微血管病：一例报告
Kidney Med. 2022 Apr 4;4(5):100461. doi: 10.1016/j.xkme.2022.100461. eCollection 2022 May.
6
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.
7
Thrombotic microangiopathy in the early post-renal transplant period.肾移植术后早期的血栓性微血管病
Ren Fail. 2008;30(2):199-203. doi: 10.1080/08860220701810547.
8
Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity.肾移植后血栓性微血管病：一种诊断不足且可能可逆的病症。
Front Med (Lausanne). 2021 Apr 8;8:642864. doi: 10.3389/fmed.2021.642864. eCollection 2021.
9
A systematic review of diagnostic, prognostic, and risk blood and urine biomarkers of transplant-associated thrombotic microangiopathy.移植相关性血栓性微血管病的诊断、预后和风险的血液和尿液生物标志物的系统评价。
Front Immunol. 2023 Feb 2;13:1064203. doi: 10.3389/fimmu.2022.1064203. eCollection 2022.
10
Renal Histopathological Changes in Coronavirus Disease 2019 Patients: A Systematic Review and Meta-analysis of Individual Patient Data.2019 年冠状病毒病患者的肾脏组织病理学变化：一项个体患者数据的系统回顾和荟萃分析。
Saudi J Kidney Dis Transpl. 2021 Nov-Dec;32(6):1523-1544. doi: 10.4103/1319-2442.352410.

本文引用的文献

1
Nintedanib-Induced Renal Thrombotic Microangiopathy.尼达尼布诱发的肾血栓性微血管病。
Case Rep Nephrol Dial. 2021 Jul 22;11(2):227-232. doi: 10.1159/000517692. eCollection 2021 May-Aug.
2
Nintedanib-induced glomerular microangiopathy: a case report.尼达尼布致肾小球微血管病：病例报告。
CEN Case Rep. 2020 Nov;9(4):295-300. doi: 10.1007/s13730-020-00474-w. Epub 2020 Apr 11.
3
Renal thrombotic microangiopathy during nintedanib treatment for idiopathic pulmonary fibrosis
.尼达尼布治疗特发性肺纤维化期间的肾血栓性微血管病
Clin Nephrol. 2020 Jan;93(1):47-50. doi: 10.5414/CN109900.
4
Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.接受血管内皮生长因子抑制剂治疗的癌症患者的肾脏疾病临床病理谱：5例报告及文献复习
Hum Pathol. 2014 Sep;45(9):1918-27. doi: 10.1016/j.humpath.2014.05.015. Epub 2014 Jun 12.